Related Experiment Videos
Lichenoid dermatitis--treatment with pulsed dye laser: a case study
Bärbel Greve1, Wolfgang Hartschuh, Christian Raulin
1Department of Dermatology, University Hospital of Heidelberg, Heidelberg, Germany.
Lasers in Surgery and Medicine
|July 19, 2002
Summary
The pulsed dye laser effectively treated drug-induced lichenoid dermatosis resistant to corticosteroids. This laser therapy offers a safe and scar-free solution for inflammatory skin conditions.
Area of Science:
- Dermatology
- Laser Therapy
- Inflammatory Dermatoses
Background:
- Lichenoid dermatosis diagnosis and treatment present challenges.
- Flashlamp-pumped pulsed dye laser (PDL) shows promise for inflammatory dermatoses.
- PDL's mechanism in these conditions requires further elucidation.
Observation:
- A female patient with presumed drug-induced lichenoid dermatitis was treated.
- Previous treatment with topical corticosteroids for 10 months yielded no significant improvement.
- Pulsed dye laser (585 nm, 450 microseconds) was administered after drug discontinuation.
Findings:
- Six PDL treatments achieved complete clearance of lesions.
- No recurrence was observed during a 54-month follow-up period.
- No scarring or permanent pigmentary changes were noted; biopsy confirmed resolution.
Implications:
- PDL therapy accelerates clearance in corticosteroid-resistant, drug-induced lichenoid dermatoses.
- PDL presents a safe treatment option, avoiding scarring and pigmentary issues.
- Further research into PDL's efficacy for similar dermatological conditions is warranted.